Healthcare provider profile · identity verified

Karin B Kuhl, MD

Internal Medicine · ASHLAND, OR · NPI 1689722795

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	408	128
Levothyroxine Sodium	Levothyroxine Sodium	401	111
Amlodipine Besylate	Amlodipine Besylate	240	82
Losartan Potassium	Losartan Potassium	223	73
Trazodone Hcl	Trazodone Hcl	210	66
Rosuvastatin Calcium	Rosuvastatin Calcium	183	62
Eliquis	Apixaban	140	33
Citalopram Hbr	Citalopram Hydrobromide	137	40
Metoprolol Succinate	Metoprolol Succinate	135	44
Lisinopril	Lisinopril	131	38
Gabapentin	Gabapentin	110	44
Omeprazole	Omeprazole	93	32
Potassium Chloride	Potassium Chloride	93	27
Alendronate Sodium	Alendronate Sodium	87	26
Sertraline Hcl	Sertraline Hcl	86	28
Furosemide	Furosemide	72	21
Pravastatin Sodium	Pravastatin Sodium	70	22
Tamsulosin Hcl	Tamsulosin Hcl	65	16
Duloxetine Hcl	Duloxetine Hcl	64	19
Metformin Hcl	Metformin Hcl	61	20
Telmisartan	Telmisartan	57	22
Synthroid	Levothyroxine Sodium	54	17
Donepezil Hcl	Donepezil Hcl	49	16
Estradiol	Estradiol	49	24
Memantine Hcl	Memantine Hcl	49	15
Pantoprazole Sodium	Pantoprazole Sodium	49	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	48	25
Bupropion Xl	Bupropion Hcl	48	14
Buspirone Hcl	Buspirone Hcl	48	21
Hydrochlorothiazide	Hydrochlorothiazide	47	17
Xarelto	Rivaroxaban	47	11
Celecoxib	Celecoxib	43	15
Montelukast Sodium	Montelukast Sodium	40	suppressed
Meloxicam	Meloxicam	39	16
Carvedilol	Carvedilol	38	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	15
Metformin Hcl Er	Metformin Hcl	37	17
Fluticasone Propionate	Fluticasone Propionate	35	12
Jardiance	Empagliflozin	34	11
Mirtazapine	Mirtazapine	34	13
Propranolol Hcl	Propranolol Hcl	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	12
Lorazepam	Lorazepam	29	12
Finasteride	Finasteride	27	11
Metoprolol Tartrate	Metoprolol Tartrate	26	suppressed
Prednisone	Prednisone	26	12
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Latanoprost	Latanoprost	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	11
Valacyclovir	Valacyclovir Hcl	23	12
Famotidine	Famotidine	22	suppressed
Primidone	Primidone	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Mounjaro	Tirzepatide	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Doxepin Hcl	Doxepin Hcl	19	13
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	12
Warfarin Sodium	Warfarin Sodium	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Misoprostol	Misoprostol	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Atenolol	Atenolol	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Novolin R Flexpen	Insulin Regular, Human	12	suppressed
Topiramate	Topiramate	12	suppressed
Lovastatin	Lovastatin	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error